We investigated the genetic determination of high-density-lipoprotein cholesterol (HDL-C) levels in the NHLBI Family Heart Study by segregation analysis. Included was a total of 3755 subjects from 560 randomly selected nuclear families and 522 families selected due to a high family risk of coronary heart disease (CHD). In the whole dataset, there was no evidence for an allele at a major gene locus responsible for HDL-C levels lower than the population mean or even for significant bimodality for low levels of HDL-C. However, we observed evidence for a recessive allele that was associated with higher HDL-C levels than average. This evidence for a recessive major gene was independent of triglyceride concentrations and was most strongly observed in families recruited for CHD. The environmental model was rejected (P=0.0027) while the codominant and recessive models were not rejected (P=0.085 and P=0.133, respectively). The dominant model was also rejected (P50.0001). In the recessive segregation model, the means of those inferred to be homozygous for the high HDL-C allele and those without the high HDL-C allele were separated by about 25 mg/dl HDL-C (73.9+1.99 vs 48.2+0.36 mg/dl). Because these results were unexpected, segregation was tested in a separate sample of 2013 individuals in 85 large pedigrees ascertained for early heart disease deaths, early stroke deaths, and early hypertension in Utah. Similar evidence for an allele at a major gene locus for high HDL-C was found. In summary, we did not find evidence for an allele at a major gene locus associated with low HDL-C levels segregating in pedigrees recruited for the NHLBI Family Heart Study, or in pedigrees ascertained in Utah for early CHD or related phenotypes. Instead we found some evidence for the segregation of an allele associated with high HDL-C.
Introduction
The concentrations of high-density-lipoprotein cholesterol (HDL-C) have been demonstrated to be negatively 0.36 for HDL-C between the average parental and the child value. 10 Similar correlations were reported in the Heritage Family Study. 12 Weak parent -child correlations, however, were described in the Cuenca Study. 13 Results from the NHLBI Family Heart Study (FHS) observed in randomly selected families a correlation of 0.32 and 0.29 for parent -child and sibling -sibling HDL-C, respectively, but less than 10% of this correlation was explained by lifestyle habits such as alcohol consumption, physical exercise and smoking. 11 This is in accordance with findings in dizygotic
twins showing a correlation of 0.39 for HDL-C, which was only slightly reduced after adjustment for lifestyle and other environmental variables. 14 Furthermore, the genetic heritability was calculated to be 0.485+0.029 in data from the Lipid Research Clinics Program Family Study. 15 While heritability for plasma HDL-C levels appears to be high, efforts to fit genetic models with complex segregation analysis have led to conflicting results. Some found no evidence for a major gene, 16 -19 others found evidence for major genes with various modes of transmission 20 -26 (for details see Table 1 ). We therefore analysed the segregation of HDL-C in the NHLBI FHS as well as in a separate set of Utah pedigrees.
Subjects and methods

Population
This analysis is based on the subjects recruited for the FHS, a population-based, multicenter study aimed to identify genetic and nongenetic determinants of cardiovascular disease. Probands were identified from three parent cohort studies, the Forsyth, (NC) and Minneapolis, (MN) cohorts of the ARIC study, the Framingham Heart Study Offspring Cohort, and the Utah Family Tree Study. Extended information about design and objectives of FHS is given elsewhere. 27 In Phase I of FHS, 2000 randomly selected populationbased participants and 2000 with family histories of CHD (about 500 from each group and each of the field centres) were identified among 14 592 middle-aged participants in epidemiological studies. Medical histories from these individuals, their parents and siblings, were used to calculate family risk scores which compared the number of reported and validated CHD events with the number expected based on the size, sex and age of family members. In phase II of the study, a total of 661 families with the highest risk scores and early onset of CHD, and 592 randomly sampled families (about 150 from each group and each of the field centres) had a detailed clinical and laboratory investigation including interviews by experienced interviewers. Clinical data obtained included anthropometry, blood pressure, blood samples for laboratory tests, electrocardiogram, pulmonary function, ultrasound of carotid arteries, and questionnaires supplying information about socio-economic status, lifestyle, medical history, medication use, food intake, nicotine and alcohol consumption, physical exercise, family structure, and psychosocial characteristics.
The analyses were repeated using data from 2013 individuals in 85 Utah extended pedigrees. The majority of these subjects (most within large pedigrees) were ascertained through sibships with two or more coronary heart disease deaths before the age of 55 (18 pedigrees), or stroke deaths before the age of 75 (9 pedigrees). These families were selected through a statewide file of 140 000 death certificates computer-linked to genealogical records for 1.2 million people in Utah. The rest of the sample (most within small pedigrees) was ascertained through probands selected [20] 23 families, 132 members Probands having primary hypoalphalipoproteinemia Recessive major gene for low HDL [18] 78 nuclear families with 292 50 families by proband with maturity-onset diabetes No major gene members mellitus and 28 control families [21] 14 nuclear families, 64 members Probands having primary hypoalphalipoproteinemia Major gene for low HDL, mode of transmission unknown [22] 1 high-risk pedigree with 196 Child with positive family history of CHD Major gene with neither dominant members nor recessive expression [23] 3074 nuclear families with 1 -2 Screening of all 17-year-olds Recessive major gene for low HDL children [24] 3074 nuclear families with 1 -2 Screening of all 17-year-olds Inconclusive for high HDL children [37] 1806 families with 6821 members 1146 families selected at random, 483 by hyperMajor factor for low HDL transmitted cholesterolemic and 177 by proband with HDL from parent to offspring but unclear whether Mendelian [19] 69 families with 390 members Probands undergoing diagnostic cardiac catheterization No single gene for HDL levels [25] 28 families with 277 members Random Both Mendelian and non-Mendelian models fitted the data for high HDL [26] 25 families with 526 members Random Major codominant gene for low HDL a Analysis includes the data of the studies 39, 40 Segregation analysis of HDL cholesterol F Kronenberg et al 368 randomly from participants of the Utah center for the Hypertension Detection and Follow-up Program. Detailed characteristics of the sample are described elsewhere. 28 The subjects in this sample are 98% Caucasian; analyses were not performed on the small number of non-Caucasian subjects. There was no overlap between these families and the sample of families from Utah recruited for the FHS study.
Measurement of HDL-C and other phenotypes
After fasting for 12 h, blood samples were collected from FHS subjects in tubes with no additives. After low-speed centrifugation, serum samples were stored at 7708C until sufficient numbers of samples accumulated for shipment to the FHS Central Biochemistry Laboratory at the University of Minnesota for processing. HDL-C was measured in the supernatant after dextran sulphate-magnesium precipitation using enzymatic methods. 29, 30 Samples from Utah subjects were processed at the University of Utah Cardiovascular Genetics Program using similar methods. 14 Anthropometric measurements were collected with subjects wearing scrub suits. Weight was measured using a balance scale, and height was measured using a vertical ruler mounted to a wall. Subjects were asked to bring medications to their clinic visit, and medication use was assessed through a review of these medications and through an interview. All other variables were collected through interviews performed by trained interviewers.
Statistical analysis
We adjusted HDL-C levels within gender for age, amount of alcohol consumption, current smoking status, body mass index, waist/hip ratio, amount of TV watching as a measure of physical inactivity, estrogen substitution for postmenopausal reasons, menopausal status, and recruitment centre by the SAS GLM procedure. 31 Adjusted HDL-C values for segregation analysis were available from 560 randomly recruited Caucasian families (1896 subjects) and from 522 Caucasian families (1859 subjects) with high family risk score for CHD.
In the Utah sample, the same covariates were used with the exception of waist/hip ratio, TV watching, and recruitment centre. Waist circumference, physical activity by questionnaire, and watts needed to maintain 80% of maximum heart rate from a 4-minute bicycle test were used in the Utah HDL-C level adjustment. These adjustments were performed to ensure that a major gene effect was not disguised nor explained by effects of covariates. Other variables were not included in the final analysis after it was shown that they did not contribute to the regression model. Corrections for covariates were done separately within the FHS and Utah samples. Adjusted HDL-C levels were calculated by adding the overall mean HDL-C concentration to the calculated residuals of each individual.
Segregation analysis of adjusted HDL-C from the FHS sample was performed in the whole group of families, in the random group, and in the CHD group. For the Utah sample, the entire sample was analysed together. Maximum likelihood segregation analysis 32, 33 was done using the Pedigree Analysis Package (PAP) software. 34 This analysis was performed before adjustment of HDL-C for log transformed triglyceride concentrations and again after adjustment. Adjustment for the above variables explained 22% of the HDL-C values in FHS females (11% in Utah females) and 16% in FHS males (12% in Utah males) when triglycerides were not considered. Inclusion of triglycerides in the model increased the sex-specific variance explained to 31% (19% for Utah) and 32% (18% for Utah), respectively. A standard segregation model was tested, in which we assumed the variation in HDL-C was caused by the sum of the independent effects of alleles L and H at a major locus, polygenic inheritance, and random environmental factors specific to each individual. We assumed that the major locus alleles were in Hardy -Weinberg equilibrium. Three HDL-C phenotypic means were defined, one for each genotype (m LL , m LH , and m HH ).
Model fitting was performed searching both for an allele at a major gene locus associated with lower than average HDL-C levels as well as for an allele associated with higher than average HDL-C levels. In models investigating low HDL-C, m HH represents a mean close to the average HDL-C levels in the pedigree members and m LL represents the low HDL-C mean. When searching for evidence of an allele that raises HDL-C, m HH represents the mean of higher than average HDL-C levels. Several starting values for the three means were used. As a general rule we decreased the starting values of m LL and m LH in steps of 2 to 5 mg/dl when fitting a low HDL-C model and increased m LH and m HH when fitting a high HDL-C model. The gene frequency q is the frequency of the allele associated with the mean furthest from the average HDL-C level in the low and high HDL-C models. Homoscedasticity was assumed by defining one common parameter (s) for the standard deviation of each genotypic category. Note that the variation within a genotypic category is divided into a polygenic component and random environmental effects specific to each individual. These effects were assumed to be normally distributed. Three transmission probabilities (t 1 , t 2 , and t 3 ) were also defined. The transmission probabilities reflect the chance that a parent will transmit a specific allele to an offspring (1, 1/2, and 0 for Mendelian transmission).
The GEMINI function 35 was used to produce maximumlikelihood estimates of the parameters. Sub-models were compared to a more general model. The difference in 726ln(likelihood) of each model is approximated by a w 2 distribution, with degrees of freedom equal to the difference in the number of parameters estimated in the two models. Tests were performed as follows: first, the most general model with the three t i estimated was generated. Ascertainment correction in the FHS group recruited for early onset CHD was performed for the youngest family member with coronary artery disease or for the proband if a family member with CHD was not available for examination. This correction was performed independently whether the CHD families were analysed as a separate group or whether they were analysed together with the random families. Within PAP, the likelihood of the pedigrees given the model parameters is divided by the likelihood of the ascertainment subset to produce the final corrected likelihood. Correction for ascertainment bias will minimize the risk of making false claims of a major gene effect. 36 Analysis in the FHS group was also done without ascertainment correction which showed virtually the same results. Ascertainment corrections of the Utah pedigree data could not be done since ascertainment was on unexamined deceased founders of the extended pedigrees.
Results Table 2 presents the variables used in adjusting HDL-C for the FHS data. Model fitting was performed separately for males and females. In the model which included triglycerides, HDL-C increased in both genders with increasing alcohol consumption, physical activity, and decreased with age, body mass index, waist/hip ratio, abdominal girth, triglycerides, smoking, and in males with increasing TV watching time. In females postmenopausal status was associated with lower and estrogen use with higher HDL-C values. The distribution of HDL-C after adjustment had a skewness of 0.73 and a kurtosis of 1.07. Adjustment in the Utah data yielded similar results (data not shown).
Modelling of an allele for low HDL-C in FHS families HDL-C without adjustment for triglyceride concentrations Independently of how we set the initial estimates in the search for a locus for low HDL-C (e.g. m HH =50 mg/ dl, m LH =48 mg/dl, m LL =38 mg/dl), m LL changed to a high value above 70 mg/dl. In fact, m LL , m LH , and m HH changed to exactly the same values as we found them when using starting estimates favouring an allele that raises HDL-C above average (see below). There was no bimodality initially evident for a mean representing low values. Therefore we decided to omit those individuals with the upper 10% of HDL-C to see if either some outliers or possibly another allele related to high HDL-C caused this phenomenon.
Although there was now significant bimodality for a low HDL-C mean in the data, we did not find any evidence for an allele responsible for low HDL-C levels (P50.0001, P50.0001, and P50.005 rejecting the Mendelian vs the general model for all families, random families and the high-risk CHD families, respectively) ( Table 3) . When testing for low HDL-C levels before adjustment for triglyceride concentrations, the best model in all three FHS groups (whole, random and CHD group) was the environmental model (P=0.74, P=0.19 and P=0.53, respectively) ( Table 3 ). The environmental model parameter estimates for the whole group were as follows: q=0.29, m HH =43.7, m LH =55.0, m LL =33.6, s=6.10 and h 2 =0.91.
HDL-C adjusted for triglyceride concentrations
When we reran the analysis after additional adjustment of HDL-C for triglycerides, both the environmental and major gene models were rejected and we accepted only the general model ( Table 3 ). The general model parameter estimates for the whole group were as follows: q=0. 35 Modelling of an allele for high HDL-C in FHS families Evidence for segregation when modeling a mean for high HDL-C in the FHS families was further examined using all individuals without exclusion of subjects above or below a certain percentile. In the whole group as well as in the random group, the Mendelian and the environmental models were rejected independently of whether we adjusted for triglycerides or not, although the codominant model fitted better than the environmental model ( Table 3 ). The general model also fitted the best for the CHD group when HDL-C was not adjusted for triglycerides. After adjustment, however, it was no longer possible to reject the codominant and the recessive model in the CHD group (Table 4) . In both models, the means of the homozygote allele carriers and those without the allele were separated by about 25 mg/dl HDL-C (74.3 vs. 47.6 mg/dl for the codominant model and 73.9 vs. 48.2 mg/dl for the recessive model). The gene frequencies (q) for high HDL-C were 0.23 and 0.24 for the codominant and the recessive models, respectively. Interestingly, the mean values of the different genotypes as well as the gene frequencies (Table 3) 
Segregation in the Utah pedigrees
As with the FHS data, the Utah data produced estimates indicating a higher than average mean for HDL-C regardless of starting values. Models using HDL-C not adjusted for triglyceride resulted in rejection of both the environmental and codominant models (P50.0001; P=0.046, respectively). For HDL-C adjusted for triglycerides, The gene frequency q is the frequency of the allele associated with low and high HDL-C levels in the low and high HDL-C models, respectively. *After exclusion of subjects with HDL above the 90th percentile. {Model was rejected compared to the general model. {See Table 4 for the extended model and exact parameter estimates in the CHD group. 
Discussion
There is clear evidence of a high heritability of HDL-C concentrations. 6,9 -13,15 The mode of inheritance, however, is controversial, as can be seen in Table 1 . Friedlander et al studied 3074 nuclear families with 1 -2 children and found evidence for a recessive major gene for low HDL-C. 23 The analysis remained inconclusive for high HDL-C in the same study population. 24 Bucher et al 37 proposed a factor for low HDL-C levels transmitted from parents to offspring in a large sample of 1806 families with nearly 7000 members. It was unclear whether this transmission followed a Mendelian pattern. Byard et al described a recessive major gene for low HDL-C concentrations. 20 A study in 526 Mexican American individuals in 25 randomly ascertained families reported evidence for a major locus for low HDL-C with a codominant model. 38 Others reported either evidence for a major gene with unknown mode of transmission 21, 22, 25 or no evidence for a major gene locus. 16, 18, 19 The reasons for these divergent results might be found in differences in study design, differences in ethnic compositions of study populations, recruitment conditions and data adjustment. Although we investigated a large data set of families we did not find any evidence for a major gene allele that lowers HDL-C concentrations below average, independently of whether we adjusted for triglyceride concentrations or not. Bimodality for low HDL-C levels was not observed unless the highest 10% of HDL-C values were excluded. We accepted only the environmental model for low HDL-C before adjustment for triglycerides. The rejection of the environmental model after adjustment for triglycerides is in accordance with the inverse relation between triglyceride and HDL-C concentrations and the pronounced environmental influence on triglyceride levels.
It is surprising at first glance that we found evidence for a major allele leading to higher than average HDL-C values only in the group of families recruited for clustering of CHD, the group one would least expect to find it. We observed a recessive or codominant transmission of the inferred gene after adjusting for the effects of triglycerides on HDL-C. The mean separation and standard deviation of the different HDL-C genotype distributions as well as the gene frequencies were similar in the random and the whole group of families when compared to the CHD group. The major differences were found in the transmission probabilities which suggests that the models between the groups of families are very similar from the physiological point of view. A more pronounced confounding and/or heterogeneity in the random group of families resulting in different transmission probabilities could be an explanation for these findings. In other words, the random and CHD models for high HDL-C are very similar resulting in mild evidence for a high HDL-C allele in the entire dataset. There appears, however, to be some other factor that may be confounding the segregation in both groups but is just a little stronger in the random group (or by chance appears to be stronger).
Although we used a large number of families, these somewhat small family structures might have limited our analysis providing poor estimates of the transmission probabilities. The ascertainment correction for the FHS CHD families may not have been correct, given the complicated selection of these families. However, the correction made virtually no difference in the results when compared to an analysis without ascertainment correction (data not shown). To test for reproducibility, we obtained similar results from a set of large extended Utah pedigrees ascertained for early death due to stroke or CHD, or due to early hypertension. These similar results in an independent sample with greater segregation information support the evidence for a major allele for high HDL-C in subjects ascertained for CHD risk.
Conclusion
It appears that there is little or no evidence for a major gene allele for lower than average HDL-C levels in these data sets and that an environmental model fits best for low HDL-C. Surprisingly, the model that showed the most evidence for an allele leading to high HDL-C occurred in the CHD group, supported by similar results obtained in a Utah sample ascertained for risk of CHD and related phenotypes.
